SAFETY AND IMMUNOGENICITY OF H3N2 M2SR MONOVALENT INFLUENZA VACCINE ADMINISTERED WITH INACTIVATED FLU VACCINE IN OLDER SUBJECTS

$11,439,843FY2021Defense Health AgencyDOD

Flugen Inc

Investigators